Matches in Wikidata for { <http://www.wikidata.org/entity/Q42641839> ?p ?o ?g. }
- Q42641839 description "2009 nî lūn-bûn" @default.
- Q42641839 description "2009年の論文" @default.
- Q42641839 description "2009年論文" @default.
- Q42641839 description "2009年論文" @default.
- Q42641839 description "2009年論文" @default.
- Q42641839 description "2009年論文" @default.
- Q42641839 description "2009年論文" @default.
- Q42641839 description "2009年论文" @default.
- Q42641839 description "2009年论文" @default.
- Q42641839 description "2009年论文" @default.
- Q42641839 description "2009年论文" @default.
- Q42641839 description "2009年论文" @default.
- Q42641839 description "2009年论文" @default.
- Q42641839 description "2009년 논문" @default.
- Q42641839 description "article científic" @default.
- Q42641839 description "article scientific" @default.
- Q42641839 description "article scientifique" @default.
- Q42641839 description "articol științific" @default.
- Q42641839 description "articolo scientifico" @default.
- Q42641839 description "artigo científico" @default.
- Q42641839 description "artigo científico" @default.
- Q42641839 description "artigo científico" @default.
- Q42641839 description "artikel ilmiah" @default.
- Q42641839 description "artikull shkencor" @default.
- Q42641839 description "artikulong pang-agham" @default.
- Q42641839 description "artykuł naukowy" @default.
- Q42641839 description "artículo científico publicado en 2009" @default.
- Q42641839 description "artículu científicu espublizáu en 2009" @default.
- Q42641839 description "bilimsel makale" @default.
- Q42641839 description "bài báo khoa học" @default.
- Q42641839 description "naučni članak" @default.
- Q42641839 description "scienca artikolo" @default.
- Q42641839 description "scientific article published on 20 November 2009" @default.
- Q42641839 description "scientific article published on 20 November 2009" @default.
- Q42641839 description "scientific article published on 20 November 2009" @default.
- Q42641839 description "teaduslik artikkel" @default.
- Q42641839 description "tieteellinen artikkeli" @default.
- Q42641839 description "tudományos cikk" @default.
- Q42641839 description "vedecký článok" @default.
- Q42641839 description "vetenskaplig artikel" @default.
- Q42641839 description "videnskabelig artikel" @default.
- Q42641839 description "vitenskapelig artikkel" @default.
- Q42641839 description "vitskapeleg artikkel" @default.
- Q42641839 description "vědecký článek" @default.
- Q42641839 description "wetenschappelijk artikel" @default.
- Q42641839 description "wissenschaftlicher Artikel" @default.
- Q42641839 description "επιστημονικό άρθρο" @default.
- Q42641839 description "мақолаи илмӣ" @default.
- Q42641839 description "наукова стаття, опублікована в листопаді 2009" @default.
- Q42641839 description "научна статия" @default.
- Q42641839 description "научная статья" @default.
- Q42641839 description "научни чланак" @default.
- Q42641839 description "научни чланак" @default.
- Q42641839 description "מאמר מדעי" @default.
- Q42641839 description "مقالة علمية نشرت في 20 نوفمبر 2009" @default.
- Q42641839 description "২০ নভেম্বর ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q42641839 description "บทความทางวิทยาศาสตร์" @default.
- Q42641839 description "სამეცნიერო სტატია" @default.
- Q42641839 name "Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics." @default.
- Q42641839 name "Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial" @default.
- Q42641839 type Item @default.
- Q42641839 label "Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics." @default.
- Q42641839 label "Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial" @default.
- Q42641839 prefLabel "Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics." @default.
- Q42641839 prefLabel "Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial" @default.
- Q42641839 P1433 Q42641839-5D35AAE2-DC30-4C2F-8B59-173A255EA114 @default.
- Q42641839 P1476 Q42641839-AE61AA95-BD57-4F88-854C-BD74D6BCFE54 @default.
- Q42641839 P2093 Q42641839-36E4B305-7F75-41A4-B3F5-F8E084921006 @default.
- Q42641839 P2093 Q42641839-6C0DA485-503C-4527-A2C2-32F1F639104B @default.
- Q42641839 P2093 Q42641839-96204E37-914B-48CD-8ABB-AF7DB0B7AC14 @default.
- Q42641839 P2093 Q42641839-9C19B622-0470-4DCB-A21B-C37474964FC4 @default.
- Q42641839 P2093 Q42641839-9D75EEFD-CF9F-496E-9264-0CFD17E69413 @default.
- Q42641839 P2093 Q42641839-B92BF740-C97F-4B7D-8869-D4D5513FA183 @default.
- Q42641839 P2093 Q42641839-C1DA64DF-1AE1-4CEA-A456-DA91577B6D0E @default.
- Q42641839 P2093 Q42641839-FCFCDE37-12CC-4729-A240-7458E75D4F69 @default.
- Q42641839 P304 Q42641839-0D5D137E-20EA-456B-B897-C9FA77A7263B @default.
- Q42641839 P31 Q42641839-3CA61D8A-8B96-4124-8D3B-B534BDBB3956 @default.
- Q42641839 P356 Q42641839-5E931E4D-C6CE-4E2A-B5F8-627C4985C5AD @default.
- Q42641839 P407 Q42641839-70D4F22B-C107-444F-A413-DC1ED7D44F79 @default.
- Q42641839 P433 Q42641839-A4D6B315-6155-442B-B08F-CAA84FE78313 @default.
- Q42641839 P478 Q42641839-5D85214F-683E-44A8-8AD1-7FF992CA7B26 @default.
- Q42641839 P50 Q42641839-145A833D-170B-48E9-99FF-11B7750B76AA @default.
- Q42641839 P50 Q42641839-C9B6FF30-E669-4CA7-A762-ED79FB456B54 @default.
- Q42641839 P577 Q42641839-177C781B-C05C-45FF-9FA7-112974587B29 @default.
- Q42641839 P5875 Q42641839-A43B3640-9E23-460B-8376-F4FB236ACBB3 @default.
- Q42641839 P698 Q42641839-918BCF7C-6977-49C0-8585-D4DDC8297254 @default.
- Q42641839 P921 Q42641839-327AD48A-8DF8-4765-9E72-12DCB66F7975 @default.
- Q42641839 P921 Q42641839-F27DBD90-EE85-4E92-BD98-3E0755B78A11 @default.
- Q42641839 P356 J.EURURO.2009.11.029 @default.
- Q42641839 P698 19962227 @default.
- Q42641839 P1433 Q15763991 @default.
- Q42641839 P1476 "Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics" @default.
- Q42641839 P2093 "Bo-Eric Persson" @default.
- Q42641839 P2093 "E David Crawford" @default.
- Q42641839 P2093 "Fritz Schröder" @default.
- Q42641839 P2093 "Jens-Kristian Jensen" @default.
- Q42641839 P2093 "Judd Moul" @default.
- Q42641839 P2093 "Kurt Miller" @default.
- Q42641839 P2093 "Neal Shore" @default.
- Q42641839 P2093 "Tine Kold Olesen" @default.